NHGRI logo

The criteria for notable accomplishments:

  • Involve use of patients’ genomic variant information in clinical decision making.
  • Demonstrate impact of direct clinical implementation on health outcomes or behaviors.
  • Are likely to be generalizable beyond original setting.
  • Are likely to have implications for healthcare systems or practice guidelines.
  • Are sufficiently large and rigorous to overcome sampling error and other bias.
  • Are broadly representative of the field beyond NHGRI-sponsored or US-funded programs.

Categories for the notable accomplishments of research are defined (below) as research that uses genomics to generate or study.

Category Information Content
Genomic Medicine Resource Genomic medicine educational materials or guidelines.
Pilot Implementation Preliminary evidence that suggest a need for broader research for the systematic uptake of genomic research findings and other evidence-based practices into routine practice.
Systematic Implementation Uptake of genomics into patients’ medical care with definition and measurement of health and implementation outcomes (e.g., acceptability, cost, feasibility, etc.).
Risk Assessment/Prediction How a person’s genes can be used to estimate their risk to develop a disease or condition.
Pharmacogenomics How a person’s genetic variation affects how they respond to medications.
Oncology Use of genomics for the treatment and management of cancer excluding cancer risk estimation since included in “Risk Assessment/Prediction.”
Undiagnosed Diseases Use of genomics to identify the etiology of unexplained disease.
Gene-Disease Validation Definitive evidence supporting or refuting a claim that variation in a particular gene causes a particular disease in humans, including evidence from in vitro technologies or model organisms.
Sequencing Use of genetic sequencing for patients’ medical care.
Variant Classification How a genetic alteration influences an individual's susceptibility or predisposition to a certain phenotype.
Impact/Outcomes Compelling evidence of the impact of genomic based interventions on patient outcomes.
Secondary Findings Interpretation of genetic test results identified in a gene unrelated to the primary purpose for the testing.
Health Disparities Genomics’ role in differences in human health that are closely linked with social or economic disadvantage.
Other Genomic medicine subject that is different or distinct from one of the already listed categories.

Last updated: December 2, 2020